On the morning of June 5, wangshunfa, deputy secretary and vice chairman of the Political Consultative Group of Lishui Municipal Committee of the Chinese people's Political Consultative Conference, led the research team to visit Benefit pharmaceutical to carry out special research. Zhouzhifei, a second-class inspector of the Economic Committee of the Municipal People's Political Consultative Conference, lijianjun, director of the Economic Committee of the Municipal People's Political Consultative Conference, Zhong Shande, deputy director of the Economic Committee of the Municipal People's Political Consultative Conference, Wu Lingfang, deputy director of the Municipal Bureau of economy and information technology, Wang Cheng, deputy director of the Municipal Bureau of science and technology, and other relevant department heads accompanied the investigation. Wulihua, chairman of Benefit pharmaceutical, and senior executives of the company received the survey.

1.jpg

Wulihua, chairman of Benefit pharmaceuticals, extended a warm welcome to the research group and the delegation, accompanied them into the Benefit traditional Chinese medicine culture and technology exhibition hall, systematically explained the in-depth layout of enterprises in the whole industry chain of traditional Chinese medicine, and introduced in detail the "Benefit pharmaceutical great health smart future factory" project.

2.jpg

Vice chairman wangshunfa spoke highly of the practical achievements of Benefit medicine in the field of traditional Chinese medicine. He pointed out that the key to the revitalization of the cause of traditional Chinese medicine is to consolidate the industrial foundation. The construction of the first industry is the source of water, and the upgrading of the second industry is the core engine. Benefit Pharmaceutical Group guaranteed the quality of raw materials with genuine medicinal materials, improved the industrial efficiency with modern pharmaceutical technology, and walked out of a characteristic path of deep integration of "seed, production, research and marketing", setting a benchmark for the industry. He stressed that local enterprises need to give full play to the advantages of Lishui's ecological resources, transform the brand value of genuine medicinal materials into industrial competitiveness, and promote the modernization of traditional Chinese medicine.

This survey not only reflects the great importance attached by Lishui CPPCC to the development of traditional Chinese medicine industry, but also injects development confidence into local enterprises. Benefit medicine will take this guidance as an opportunity to continue to give full play to its own advantages, help Lishui build a strong city of traditional Chinese medicine, and contribute local strength to the "healthy China" strategy.